Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
EUDA Health Holdings Limited (EUDA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: EUDA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $6
1 Year Target Price $6
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -47.13% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 85.44M USD | Price to earnings Ratio 113 | 1Y Target Price 6 |
Price to earnings Ratio 113 | 1Y Target Price 6 | ||
Volume (30-day avg) 1 | Beta -0.13 | 52 Weeks Range 1.03 - 4.50 | Updated Date 01/9/2026 |
52 Weeks Range 1.03 - 4.50 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.02 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.17% | Operating Margin (TTM) -37.03% |
Management Effectiveness
Return on Assets (TTM) -63.92% | Return on Equity (TTM) - |
Valuation
Trailing PE 113 | Forward PE 13.3 | Enterprise Value 87552813 | Price to Sales(TTM) 16.56 |
Enterprise Value 87552813 | Price to Sales(TTM) 16.56 | ||
Enterprise Value to Revenue 16.97 | Enterprise Value to EBITDA -25.9 | Shares Outstanding 37807491 | Shares Floating 18403184 |
Shares Outstanding 37807491 | Shares Floating 18403184 | ||
Percent Insiders 49.6 | Percent Institutions 1.02 |
Upturn AI SWOT
EUDA Health Holdings Limited
Company Overview
History and Background
EUDA Health Holdings Limited (HKSE: 1738) is a digital healthcare company that primarily operates in Singapore and Malaysia. Founded in 2017, the company aims to provide integrated digital healthcare services. Key milestones include its listing on the Hong Kong Stock Exchange in 2019 and subsequent expansion of its service offerings and geographical reach within Southeast Asia.
Core Business Areas
- Digital Healthcare Platform: Development and operation of an integrated digital healthcare platform offering services like online consultations, appointment booking, electronic health records, and prescription delivery.
- Telemedicine Services: Provision of remote medical consultations with licensed doctors, enabling patients to access healthcare from the convenience of their homes.
- Health & Wellness Services: Offering a range of health and wellness programs, including chronic disease management, mental wellness support, and general health advice.
- Pharmaceutical and Medical Supplies: Distribution of pharmaceuticals, medical devices, and other health-related products through its online platform and partnerships.
Leadership and Structure
EUDA Health Holdings Limited is led by a management team with experience in healthcare and technology. The company's structure is designed to support its digital-first approach, with departments focusing on platform development, clinical operations, marketing, and business development. Specific leadership details, such as CEO and board members, would typically be found in their investor relations materials.
Top Products and Market Share
Key Offerings
- Telemedicine Consultation Platform: An online portal and mobile application connecting patients with doctors for remote consultations. Market share data is not readily available for specific product lines, but it competes with established telemedicine providers in Southeast Asia. Competitors include DoctorOnCall, WhiteCoat, and various hospital-affiliated telehealth services.
- Digital Health Records System: A system for storing and managing patient health information electronically. This is a foundational component of their platform, aiming for integration across services. Competitors include EHR providers in the healthcare IT sector.
- Online Pharmacy and Prescription Delivery: Facilitates the ordering of prescription medications and delivery to patients. Competes with traditional pharmacies and other online drugstores. Competitors include established pharmacy chains with online presence and dedicated e-pharmacies.
Market Dynamics
Industry Overview
The digital healthcare and telemedicine market in Southeast Asia is experiencing rapid growth, driven by increasing internet penetration, smartphone adoption, rising healthcare costs, and a growing demand for convenient and accessible medical services. The COVID-19 pandemic significantly accelerated the adoption of telemedicine. Regulatory frameworks are evolving to support digital health services.
Positioning
EUDA Health Holdings Limited is positioned as an integrated digital healthcare provider aiming to bridge the gap between patients and healthcare professionals in underserved areas or for those seeking convenience. Its competitive advantages lie in its comprehensive platform offering, focus on the Southeast Asian market, and potential for partnerships with local healthcare providers and insurers.
Total Addressable Market (TAM)
The TAM for digital healthcare in Southeast Asia is substantial and growing, estimated to be in the billions of dollars. This includes telemedicine, digital therapeutics, health IT solutions, and online pharmacies. EUDA Health Holdings Limited aims to capture a significant portion of this market by offering an end-to-end digital healthcare solution.
Upturn SWOT Analysis
Strengths
- Integrated digital healthcare platform offering a comprehensive suite of services.
- Focus on the growing Southeast Asian market.
- Potential for strategic partnerships with healthcare providers and insurers.
- Agile technology-driven business model.
Weaknesses
- Brand recognition may be lower compared to established healthcare players.
- Dependence on technology infrastructure and internet connectivity.
- Regulatory complexities in different regional markets.
- Need for continuous innovation to stay competitive.
Opportunities
- Increasing adoption of telemedicine and digital health solutions post-pandemic.
- Expansion into new geographical markets within Southeast Asia.
- Development of specialized digital health services (e.g., chronic disease management, mental health).
- Leveraging data analytics for personalized healthcare.
Threats
- Intense competition from existing healthcare providers and new digital entrants.
- Changes in government regulations and data privacy laws.
- Cybersecurity risks and data breaches.
- Economic downturns affecting consumer spending on healthcare.
Competitors and Market Share
Key Competitors
- DoctorOnCall (Malaysia)
- WhiteCoat (Singapore)
- SingHealth (Singapore - Hospital Group with Telehealth)
Competitive Landscape
EUDA Health Holdings Limited competes in a dynamic and evolving digital health landscape. Its advantages include a comprehensive service offering and a focused regional strategy. However, it faces strong competition from both established healthcare institutions expanding their digital reach and specialized telemedicine platforms with significant user bases. Differentiating through user experience, service quality, and strategic partnerships will be crucial.
Growth Trajectory and Initiatives
Historical Growth: EUDA Health Holdings Limited has demonstrated growth in its user base and service offerings since its inception. Historical growth would be characterized by expansion of its platform features, onboarding of more healthcare professionals, and increasing patient engagement.
Future Projections: Future projections are typically based on analyst reports and company guidance. Analysts would likely project continued growth in the digital health sector in Southeast Asia, with EUDA Health Holdings Limited expected to benefit from market trends and its expansion strategies. Factors influencing projections include market penetration, new service introductions, and economic conditions.
Recent Initiatives: Recent initiatives might include partnerships with insurance providers, development of new digital health modules (e.g., for specific chronic conditions), expansion into new cities or countries within the region, and enhancement of their AI capabilities for personalized health recommendations.
Summary
EUDA Health Holdings Limited is a digital healthcare provider focused on the growing Southeast Asian market. Its integrated platform offers telemedicine, health records, and online pharmacy services. The company benefits from the increasing demand for convenient healthcare but faces stiff competition and regulatory challenges. Continued investment in technology and strategic expansion will be key to its future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company investor relations websites and filings
- Financial news and market data providers
- Industry reports on digital health in Southeast Asia
Disclaimers:
This analysis is based on publicly available information and is intended for informational purposes only. It does not constitute financial advice. Investors should conduct their own due diligence before making any investment decisions. Market share data and competitor information are estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About EUDA Health Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-12-14 | CEO & Executive Director Mr. Alfred Lim | ||
Sector Real Estate | Industry Real Estate Services | Full time employees 117 | Website https://eudahealth.com |
Full time employees 117 | Website https://eudahealth.com | ||
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.